Goldberg, David J.
Hu, Chenwei
Lubert, Adam M.
Rathod, Rahul H.
Penny, Daniel J.
Petit, Christopher J.
Schumacher, Kurt R.
Ginde, Salil
Williams, Richard V.
Yoon, J. K.
Kim, Gi Beom
Nowlen, Todd T.
DiMaria, Michael V.
Frischhertz, Benjamin P.
Wagner, Jonathan B.
McHugh, Kimberly E.
McCrindle, Brian W.
Cartoski, Mark J.
Detterich, Jon A.
Yetman, Anji T.
John, Anitha S.
Richmond, Marc E.
Yung, Delphine
Payne, R. Mark
Mackie, Andrew S.
Davis, Christopher K.
Shahanavaz, Shabana
Hill, Kevin D.
Almaguer, Marisa
Zak, Victor
McBride, Michael G.
Goldstein, Bryan H.
Pearson, Gail D.
Paridon, Stephen M.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis
https://doi.org/10.1007/s00246-023-03204-y
Funding for this research was provided by:
National Heart, Lung, and Blood Institute
Article History
Received: 1 March 2023
Accepted: 31 May 2023
First Online: 29 June 2023
Declarations
:
: DG received grant funding from Mezzion and NHLBI and is a co-inventor on a method of use for udenafil in adolescents who have undergone Fontan, CH none, AL none, RR none, DP received a consulting fee from Mezzion Pharma Co. Ltd., CP none, KS none, SG none, RW none, JY none, GK none, TK none, MD none, BF none, JW receives funding from the National Center for Advancing Translational Science, KM none, BM is a consultant for Janssen, Chiesi, Esperion, Ultragenyx, and Amryt Pharma, MC none, JD none, AY none, AJ none, MR none, DY none, RP none, AM none, CD none, SS none, KH receives funding from the National Center for Advancing Translational Sciences, MA none, VZ none, MM none, BG is a consultant for Mezzion Pharma, Medtronic, W.L. Gore, and PECA Labs, GP none, and SP received grant funding from NHLBI.